Tailoring the effect of antithrombin-targeting therapy in haemophilia A using in silico thrombin generation
Abstract Factor (F) VIII deficiency causes bleeding in haemophilia A patients because of the reduced formation of procoagulant enzyme thrombin, which is needed to make the blood clot. We measured the dynamics of coagulation in haemophilia A patients by measuring thrombin generation (TG). Additionall...
Guardado en:
Autores principales: | Romy M. W. de Laat-Kremers, Marisa Ninivaggi, Iris van Moort, Moniek de Maat, Bas de Laat |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7b708bf173ce43118f2e527cc850cad9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
- Haemophilia
-
HAEMOPHILIA AND NURSING CARE
por: Marcela Ganzella
Publicado: (2021) -
Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients
por: María Eugenia de la Morena-Barrio, et al.
Publicado: (2021) -
Role of a thrombin generation assay in the prediction of infection severity
por: Boaz Elad, et al.
Publicado: (2021) -
Production, purification and characterization of recombinant human antithrombin III by Saccharomyces cerevisiae
por: Mallu,Maheswara Reddy, et al.
Publicado: (2016)